We are monitoring the impact of COVID-19 on Haemostatic Agents Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4371
Share on
Share on

Global Haemostatic Agents Market Analysis - By Type, Treatment, End-User and Region – Industry Size, Share, Growth, Trends and Forecast | 2019 – 2024

Pulished: February, 2020
ID: 4371
Pages: 185

Global Haemostatic Agents Market Size

The global market size for Haemostatic Agents Market is estimated to grow at a CAGR of 7.2% from 2019 to 2024.

What are Haemostatic Agents?

Haemostatic Agents refers to the class of substances that are usually used to promote haemostasis or to stop bleeding. Haemostats are the technical term given to instruments used to reduce or halt bleeding during a surgical procedure.

The major technological advancements in the field have increased the usage of haemostats in surgical procedures in recent times. Common problems faced by haemostats include tissue contamination and ease of usage. These have been addressed in the latest wave of innovations

The major factors affecting the Haemostatic Agents market include the rising prevalence of diseases and rising awareness regarding the latest medical practices. Other drivers include increasing health consciousness among consumers, use of new inventions and enhanced technologies.

As for the restraints of the market, the high costs and the unfavourable reimbursement policies are the major hurdles. This along with the fact that people are not aware of the latest developments in developing and underdeveloped countries restrain the market growth.

Growth opportunities for the Haemostatic Agents Market lie in increasing awareness over the usage of hemostats instruments across the world. The rise in the demand for surgical procedures to treat various diseases is likely to outshine the demand of the market. Escalating expenditure on health care, especially in urban areas, is boosting up the growth rate of haemostatic agents market. Growing tendency to improve the services in hospitals and to promote wellbeing of the patient after treatment is ascribed to bolster the demand of the market. Increasing geriatric population is also one of the factors propelling the growth rate of the haemostatic agents market. The rise in the number of people suffering from chronic diseases like cancer, ophthalmic injuries and replacement, diabetes, urological disorders and many others where there is a particular need for surgical procedures is propelling the demand of the market to the extent.

Recent Developments:

  • In June 2019, FDA approved VISTASEAL open and laparoscopic Dual applicators introduced Ethicon. These devices are used for next-generation technology and can be addressed for modern surgical bleeding. 
  • In December 2018, Baxter International Inc. introduced haemostatic agent for ENT surgical procedures which is an additional curved applicator for Floseal. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Type, Treatment, End User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Ethicon, Pfizer, Baxter International, R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies and Z-Medica.

 

This research report on the Global Haemostatic Agents Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

Haemostatic Agents Market Analysis – By Type:

  • Thrombin Based Haemostats          
  • Gelatin Based Haemostats               
  • Collagen Based Haemostats            
  • Oxidized Regenerated Cellulose Based Haemostats             
  • Combination Haemostats 
  • Fibrin Sealants       
  • Others      

On the basis of type, Thrombin based haemostats type is leading with the highest shares of the market. Gelatin based haemostats segment is to have the highest CAGR in the coming years. Growing awareness over the benefits of these devices in the medical sector is magnifying the growth rate of these segments. In addition, initiative steps by the government are also accelerating the demand of the market. 

Haemostatic Agents Market Analysis – By Treatment:

  • Cardiovascular       
  • General Surgery   
  • Digestive Surgery 
  • Neurosurgery        
  • Others      

Based on treatment, the cardiovascular segment is ruling with prominent shares of the market. Rise in cardiovascular problems due to changes in lifestyles and food habits are mainly fueling the demand of the market. General Surgery segment is holding the second position in leading the shares.

Haemostatic Agents Market Analysis – By End User:

  • Hospitals  
  • Surgery Centres    
  • Nursing Homes     
  • Others      

On the basis of end user, the hospital's sector is having dominant shares from the past years and is also to grow at a steady pace in foreseen years. The construction of hospitals and clinics with the latest technology is promoting the demand for this market.

Regional Analysis:

The Haemostatic Agents Market is dominated by North America in 2019 with the region accounting for 36% of the overall market share. North America was followed next in line by Europe and Asia-Pacific. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. Another promising region for the market in Latin America, which is expected to show high growth rates in the coming years.

Top companies in the market

The Haemostatic Agents market is highly competitive with a large number of players. Haemostatic Agents Industry Key players dominating the market with their products and services are

  1. Ethicon
  2. Pfizer
  3. Baxter International
  4. C R Bard
  5. The Medicines Company
  6. Anika Therapeutics
  7. Advanced Medical Solutions
  8. Integra LifeSciences
  9. B Braun Melsungen
  10. Gelita Medical
  11. Equimedical
  12. Vascular Solutions
  13. Marine Polymer Technologies
  14. Z-Medica

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Thrombin Based Haemostats          

                                5.1.3 Gelatin Based Haemostats               

                                5.1.4 Collagen Based Haemostats            

                                5.1.5 Oxidized Regenerated Cellulose Based Haemostats             

                                5.1.6 Combination Haemostats 

                                5.1.7 Fibrin Sealants       

                                5.1.8 Others      

                                5.1.9  Y-o-Y Growth Analysis, By Type    

                                5.1.10  Market Attractiveness Analysis, By Type                

                                5.1.11  Market Share Analysis, By Type  

                5.2 Treatment                  

                                5.2.1 Introduction           

                                5.2.2 Cardiovascular       

                                5.2.3 General Surgery   

                                5.2.4 Digestive Surgery 

                                5.2.5 Neurosurgery        

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Treatment          

                                5.2.8 Market Attractiveness Analysis, By Treatment        

                                5.2.9 Market Share Analysis, By Treatment         

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Surgery Centres    

                                5.3.4 Nursing Homes     

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7  Market Attractiveness Analysis, By End User          

                                5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Treatment

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Treatment

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Treatment

                                                6.1.5.4 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Ethicon                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer                            

                8.3 Baxter International                               

                8.4 R. Bard                          

                8.5 The Medicines Company                      

                8.6 Anika Therapeutics                 

                8.7 Advanced Medical Solutions                               

                8.8 Integra Life Sciences                               

                8.9 Gelita Medical                           

                8.10 Z-Medica                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Haemostatic Agents Market By Region, From 2019-2024 ( USD Million )
  2. Global Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  3. Global Thrombin Based Market By Region, From 2019-2024 ( USD Million )
  4. Global Gelatin Based Market By Region, From 2019-2024 ( USD Million )
  5. Global Collagen Based Market By Region, From 2019-2024 ( USD Million )
  6. Global Oxidized Regenerated Cellulose Based Market By Region, From 2019-2024 ( USD Million )
  7. Global Combination Haemostats Market By Region, From 2019-2024 ( USD Million )
  8. Global Fibrin Sealants Market By Region, From 2019-2024 ( USD Million )
  9. Global Others Market By Region, From 2019-2024 ( USD Million )
  10. Global Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  11. Global Cardiovascular Market By Region, From 2019-2024 ( USD Million )
  12. Global General Surgery Market By Region, From 2019-2024 ( USD Million )
  13. Global Digestive Surgery Market By Region, From 2019-2024 ( USD Million )
  14. Global Neurosurgery Market By Region, From 2019-2024 ( USD Million )
  15. Global Others Market By Region, From 2019-2024 ( USD Million )
  16. Global Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  17. Global Hospitals Market By Region, From 2019-2024 ( USD Million )
  18. Global Surgery Centres Market By Region, From 2019-2024 ( USD Million )
  19. Global Nursing Homes Market By Region, From 2019-2024 ( USD Million )
  20. Global Others Market By Region, From 2019-2024 ( USD Million )
  21. North America Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  22. North America Thrombin Based Market By Region, From 2019-2024 ( USD Million )
  23. North America Gelatin Based Market By Region, From 2019-2024 ( USD Million )
  24. North America Collagen Based Market By Region, From 2019-2024 ( USD Million )
  25. North America Oxidized Regenerated Cellulose Based Market By Region, From 2019-2024 ( USD Million )
  26. North America Combination Haemostats Market By Region, From 2019-2024 ( USD Million )
  27. North America Fibrin Sealants Market By Region, From 2019-2024 ( USD Million )
  28. North America Others Market By Region, From 2019-2024 ( USD Million )
  29. North America Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  30. North America Cardiovascular Market By Region, From 2019-2024 ( USD Million )
  31. North America General Surgery Market By Region, From 2019-2024 ( USD Million )
  32. North America Digestive Surgery Market By Region, From 2019-2024 ( USD Million )
  33. North America Neurosurgery Market By Region, From 2019-2024 ( USD Million )
  34. North America Others Market By Region, From 2019-2024 ( USD Million )
  35. North America Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  36. North America Hospitals Market By Region, From 2019-2024 ( USD Million )
  37. North America Surgery Centres Market By Region, From 2019-2024 ( USD Million )
  38. North America Nursing Homes Market By Region, From 2019-2024 ( USD Million )
  39. North America Others Market By Region, From 2019-2024 ( USD Million )
  40. United States Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  41. United States Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  42. United States Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  43. Canada Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  44. Canada Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  45. Canada Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  46. Europe Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  47. Europe Thrombin Based Market By Region, From 2019-2024 ( USD Million )
  48. Europe Gelatin Based Market By Region, From 2019-2024 ( USD Million )
  49. Europe Collagen Based Market By Region, From 2019-2024 ( USD Million )
  50. Europe Oxidized Regenerated Cellulose Based Market By Region, From 2019-2024 ( USD Million )
  51. Europe Combination Haemostats Market By Region, From 2019-2024 ( USD Million )
  52. Europe Fibrin Sealants Market By Region, From 2019-2024 ( USD Million )
  53. Europe Others Market By Region, From 2019-2024 ( USD Million )
  54. Europe Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  55. Europe Cardiovascular Market By Region, From 2019-2024 ( USD Million )
  56. Europe General Surgery Market By Region, From 2019-2024 ( USD Million )
  57. Europe Digestive Surgery Market By Region, From 2019-2024 ( USD Million )
  58. Europe Neurosurgery Market By Region, From 2019-2024 ( USD Million )
  59. Europe Others Market By Region, From 2019-2024 ( USD Million )
  60. Europe Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  61. Europe Hospitals Market By Region, From 2019-2024 ( USD Million )
  62. Europe Surgery Centres Market By Region, From 2019-2024 ( USD Million )
  63. Europe Nursing Homes Market By Region, From 2019-2024 ( USD Million )
  64. Europe Others Market By Region, From 2019-2024 ( USD Million )
  65. U.K. Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  66. U.K. Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  67. U.K. Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  68. Germany Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  69. Germany Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  70. Germany Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  71. France Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  72. France Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  73. France Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  74. Italy Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  75. Italy Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  76. Italy Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  77. Spain Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  78. Spain Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  79. Spain Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  80. Asia Pacific Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  81. Asia Pacific Thrombin Based Market By Region, From 2019-2024 ( USD Million )
  82. Asia Pacific Gelatin Based Market By Region, From 2019-2024 ( USD Million )
  83. Asia Pacific Collagen Based Market By Region, From 2019-2024 ( USD Million )
  84. Asia Pacific Oxidized Regenerated Cellulose Based Market By Region, From 2019-2024 ( USD Million )
  85. Asia Pacific Combination Haemostats Market By Region, From 2019-2024 ( USD Million )
  86. Asia Pacific Fibrin Sealants Market By Region, From 2019-2024 ( USD Million )
  87. Asia Pacific Others Market By Region, From 2019-2024 ( USD Million )
  88. Asia Pacific Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  89. Asia Pacific Cardiovascular Market By Region, From 2019-2024 ( USD Million )
  90. Asia Pacific General Surgery Market By Region, From 2019-2024 ( USD Million )
  91. Asia Pacific Digestive Surgery Market By Region, From 2019-2024 ( USD Million )
  92. Asia Pacific Neurosurgery Market By Region, From 2019-2024 ( USD Million )
  93. Asia Pacific Others Market By Region, From 2019-2024 ( USD Million )
  94. Asia Pacific Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  95. Asia Pacific Hospitals Market By Region, From 2019-2024 ( USD Million )
  96. Asia Pacific Surgery Centres Market By Region, From 2019-2024 ( USD Million )
  97. Asia Pacific Nursing Homes Market By Region, From 2019-2024 ( USD Million )
  98. Asia Pacific Others Market By Region, From 2019-2024 ( USD Million )
  99. Japan Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  100. Japan Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  101. Japan Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  102. China Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  103. China Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  104. China Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  105. India Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  106. India Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  107. India Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  108. Australia Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  109. Australia Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  110. Australia Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  111. South Korea Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  112. South Korea Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  113. South Korea Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  114. Latin America Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  115. Latin America Thrombin Based Market By Region, From 2019-2024 ( USD Million )
  116. Latin America Gelatin Based Market By Region, From 2019-2024 ( USD Million )
  117. Latin America Collagen Based Market By Region, From 2019-2024 ( USD Million )
  118. Latin America Oxidized Regenerated Cellulose Based Market By Region, From 2019-2024 ( USD Million )
  119. Latin America Combination Haemostats Market By Region, From 2019-2024 ( USD Million )
  120. Latin America Fibrin Sealants Market By Region, From 2019-2024 ( USD Million )
  121. Latin America Others Market By Region, From 2019-2024 ( USD Million )
  122. Latin America Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  123. Latin America Cardiovascular Market By Region, From 2019-2024 ( USD Million )
  124. Latin America General Surgery Market By Region, From 2019-2024 ( USD Million )
  125. Latin America Digestive Surgery Market By Region, From 2019-2024 ( USD Million )
  126. Latin America Neurosurgery Market By Region, From 2019-2024 ( USD Million )
  127. Latin America Others Market By Region, From 2019-2024 ( USD Million )
  128. Latin America Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  129. Latin America Hospitals Market By Region, From 2019-2024 ( USD Million )
  130. Latin America Surgery Centres Market By Region, From 2019-2024 ( USD Million )
  131. Latin America Nursing Homes Market By Region, From 2019-2024 ( USD Million )
  132. Latin America Others Market By Region, From 2019-2024 ( USD Million )
  133. Brazil Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  134. Brazil Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  135. Brazil Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  136. Argentina Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  137. Argentina Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  138. Argentina Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  139. Mexico Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  140. Mexico Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  141. Mexico Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  142. Rest of Latin America Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  143. Rest of Latin America Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  144. Rest of Latin America Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  145. Middle East and Africa Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  146. Middle East and Africa Thrombin Based Market By Region, From 2019-2024 ( USD Million )
  147. Middle East and Africa Gelatin Based Market By Region, From 2019-2024 ( USD Million )
  148. Middle East and Africa Collagen Based Market By Region, From 2019-2024 ( USD Million )
  149. Middle East and Africa Oxidized Regenerated Cellulose Based Market By Region, From 2019-2024 ( USD Million )
  150. Middle East and Africa Combination Haemostats Market By Region, From 2019-2024 ( USD Million )
  151. Middle East and Africa Fibrin Sealants Market By Region, From 2019-2024 ( USD Million )
  152. Middle East and Africa Others Market By Region, From 2019-2024 ( USD Million )
  153. Middle East and Africa Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  154. Middle East and Africa Cardiovascular Market By Region, From 2019-2024 ( USD Million )
  155. Middle East and Africa General Surgery Market By Region, From 2019-2024 ( USD Million )
  156. Middle East and Africa Digestive Surgery Market By Region, From 2019-2024 ( USD Million )
  157. Middle East and Africa Neurosurgery Market By Region, From 2019-2024 ( USD Million )
  158. Middle East and Africa Others Market By Region, From 2019-2024 ( USD Million )
  159. Middle East and Africa Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  160. Middle East and Africa Hospitals Market By Region, From 2019-2024 ( USD Million )
  161. Middle East and Africa Surgery Centres Market By Region, From 2019-2024 ( USD Million )
  162. Middle East and Africa Nursing Homes Market By Region, From 2019-2024 ( USD Million )
  163. Middle East and Africa Others Market By Region, From 2019-2024 ( USD Million )
  164. Middle East Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  165. Middle East Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  166. Middle East Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )
  167. Africa Haemostatic Agents Market By Type, From 2019-2024 ( USD Million )
  168. Africa Haemostatic Agents Market By Treatment, From 2019-2024 ( USD Million )
  169. Africa Haemostatic Agents Market By End Users, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample